In addition, we found that CSRP2 overexpression increased p130Cas protein levels in GBM cells (Fig. 6E, F), whereas CSRP2 knockdown decreased p130Cas protein levels (Fig. 6G, H). This evidence concerns the gene CSRP2 and glioblastoma.